Ginger Capsules for the Acute Treatment of Migraine Attacks

• Status: Completed
• Trial end date: 2014-10-01
• Target enrollment: 0
• Participant gender: All

Summary

The main objective of the study was to evaluate ginger efficacy as an adjuvant to ketoprofen for the treatment of headache and other symptoms related with migraine attacks.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Federal University of Minas Gerais
• Treatments: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Ketoprofen

Criteria

• Inclusion Criteria:

• Migraine diagnosis for at least one year;

• Migraine attack with moderate or severe pain intensity;

• One to six migraine attacks per month.

• Exclusion Criteria:

• Patients with headaches not characterized as migraine;

• Pregnant or lactating women;

• Fertile and sexually active women who do not use contraception;

• Abuse of painkillers, alcohol or drugs;

• People with hypersensitivity to ginger;

• People with other neurological diseases;

• People in use of anticoagulant drugs;

• People who have started the disease after 50 years old.